Home Other Building Blocks Fg-4592

Fg-4592

CAS No.:
808118-40-3
Catalog Number:
AG0036GI
Molecular Formula:
C19H16N2O5
Molecular Weight:
352.3407
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
95%
In Stock USA
United States
$73
- +
10mg
95%
In Stock USA
United States
$87
- +
50mg
95%
In Stock USA
United States
$169
- +
100mg
95%
In Stock USA
United States
$219
- +
250mg
95%
In Stock USA
United States
$336
- +
500mg
95%
In Stock USA
United States
$503
- +
1g
95%
In Stock USA
United States
$769
- +
Product Description
Catalog Number:
AG0036GI
Chemical Name:
Fg-4592
CAS Number:
808118-40-3
Molecular Formula:
C19H16N2O5
Molecular Weight:
352.3407
MDL Number:
MFCD20040519
IUPAC Name:
2-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid
InChI:
InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23)
InChI Key:
YOZBGTLTNGAVFU-UHFFFAOYSA-N
SMILES:
OC(=O)CNC(=O)c1nc(C)c2c(c1O)ccc(c2)Oc1ccccc1
UNII:
X3O30D9YMX
Properties
Complexity:
508  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
352.106g/mol
Formal Charge:
0
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
352.346g/mol
Monoisotopic Mass:
352.106g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
109A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.4  
Literature
Title Journal
Cadmium Exposure Inhibits Branching Morphogenesis and Causes Alterations Consistent With HIF-1α Inhibition in Human Primary Breast Organoids. Toxicological sciences : an official journal of the Society of Toxicology 20180801
Prolyl-4-Hydroxylases Inhibitor Stabilizes HIF-1α and Increases Mitophagy to Reduce Cell Death After Experimental Retinal Detachment. Investigative ophthalmology & visual science 20160401
Targeting the hypoxia-sensing pathway in clinical hematology. Stem cells translational medicine 20140201
First-in-class anemia drug takes aim at Amgen's dominion. Nature biotechnology 20131101
Properties